Literature DB >> 31115040

Cognitive impairment in children with CACNA1A mutations.

Veronique Humbertclaude1, Florence Riant2,3, Benjamin Krams4, Valerie Zimmermann4, Nicolas Nagot5, Daniel Annequin6, Bernard Echenne4, Elisabeth Tournier-Lasserve2,3, Agathe Roubertie4,7.   

Abstract

AIM: To describe the clinico-radiological phenotype of children with a CACNA1A mutation and to precisely evaluate their learning ability and cognitive status.
METHOD: Children between the ages of 3 and 18 years harboring a pathogenic CACNA1A mutation associated with episodic ataxia, hemiplegic migraine, benign paroxysmal torticollis, benign paroxysmal vertigo, or benign paroxysmal tonic upgaze, were enrolled in this cross-sectional study. Data concerning psychomotor development, academic performance, educational management, clinical examination at inclusion, and brain imaging were collected. Cognitive assessment was performed using age-standardized scales.
RESULTS: Eighteen patients (nine males, nine females; mean age at inclusion: 11y 7mo [SD 4y 5mo; range 3y-17y 11mo]) from 14 families were enrolled. Eleven patients displayed the coexistence or consecutive occurrence of more than one type of episodic event. Nine patients exhibited abnormal neurological examination at inclusion. Brain magnetic resonance imaging (MRI) showed cerebellar atrophy in five patients. Psychomotor development was delayed in nine patients and academic difficulties were reported by the parents in 15 patients; nine patients were in special education. Impairment of intellectual function was assessed in six of the 12 patients with interpretable Full-scale IQ scores and was more frequent when cerebellar atrophy was present on MRI.
INTERPRETATION: Cognitive impairment is commonly associated with CACNA1A mutations. We suggest that CACNA1A-associated phenotype should be considered a neurodevelopmental disorder. WHAT THIS PAPER ADDS: Cognitive disabilities and academic difficulties are common in children with CACNA1A mutations associated with episodic syndromes. Cognitive function ranges from normal to moderate intellectual disorder in wheelchair-dependent children. Patients with vermian atrophy are at a higher risk of cognitive impairment.
© 2019 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31115040     DOI: 10.1111/dmcn.14261

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  12 in total

1.  The complexities of CACNA1A in clinical neurogenetics.

Authors:  Marina P Hommersom; Teije H van Prooije; Maartje Pennings; Meyke I Schouten; Hans van Bokhoven; Erik-Jan Kamsteeg; Bart P C van de Warrenburg
Journal:  J Neurol       Date:  2021-11-22       Impact factor: 6.682

2.  Hippocampus-related cognitive disorders develop in the absence of epilepsy and ataxia in the heterozygous Cacna1a mutant mice tottering.

Authors:  Akito Nakao; Katsumi Hayashida; Hiroo Ogura; Yasuo Mori; Keiji Imoto
Journal:  Channels (Austin)       Date:  2022-12       Impact factor: 3.493

3.  Cognitive dysfunction in a patient with migraine and APT1A2 mutation: a case report.

Authors:  Pian Wang; Yan-Rong Yang; Hong-Bo Zhang; Jiang-Hong Wang; Yan Wang
Journal:  Neurol Sci       Date:  2021-04-27       Impact factor: 3.307

4.  FGF14-related episodic ataxia: delineating the phenotype of Episodic Ataxia type 9.

Authors:  Julie Piarroux; Florence Riant; Véronique Humbertclaude; Ganaelle Remerand; Jessica Hadjadj; Franck Rejou; Christine Coubes; Lucile Pinson; Pierre Meyer; Agathe Roubertie
Journal:  Ann Clin Transl Neurol       Date:  2020-03-12       Impact factor: 4.511

Review 5.  Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function - Implications for Potential Therapies.

Authors:  Jörg Striessnig
Journal:  Front Synaptic Neurosci       Date:  2021-03-03

Review 6.  Calcium channelopathies and intellectual disability: a systematic review.

Authors:  Miriam Kessi; Baiyu Chen; Jing Peng; Fangling Yan; Lifen Yang; Fei Yin
Journal:  Orphanet J Rare Dis       Date:  2021-05-13       Impact factor: 4.123

Review 7.  Cognitive Impairment in Primary and Secondary Headache Disorders.

Authors:  Olivia Begasse de Dhaem; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2022-03-03

8.  Reversing frontal disinhibition rescues behavioural deficits in models of CACNA1A-associated neurodevelopment disorders.

Authors:  Alexis Lupien-Meilleur; Xiao Jiang; Mathieu Lachance; Vincent Taschereau-Dumouchel; Louise Gagnon; Catherine Vanasse; Jean-Claude Lacaille; Elsa Rossignol
Journal:  Mol Psychiatry       Date:  2021-06-14       Impact factor: 15.992

Review 9.  Paroxysmal Movement Disorders.

Authors:  Susan Harvey; Mary D King; Kathleen M Gorman
Journal:  Front Neurol       Date:  2021-06-11       Impact factor: 4.003

10.  CACNA1A Mutations Causing Early Onset Ataxia: Profiling Clinical, Dysmorphic and Structural-Functional Findings.

Authors:  Antonio F Martínez-Monseny; Albert Edo; Dídac Casas-Alba; Mercè Izquierdo-Serra; Mercè Bolasell; David Conejo; Loreto Martorell; Jordi Muchart; Laura Carrera; Carlos I Ortez; Andrés Nascimento; Baldo Oliva; José M Fernández-Fernández; Mercedes Serrano
Journal:  Int J Mol Sci       Date:  2021-05-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.